New imaging tracer aims to spot COPD damage early
NCT ID NCT02978144
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a radioactive tracer called Annexin to see if it can detect early lung damage in people with COPD and in smokers. Researchers compared scans from healthy non-smokers, healthy smokers, and people with moderate to severe COPD. The goal was to find a better way to diagnose lung damage early, but the study was stopped before completion.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Columbia University Irving Medical Center
New York, New York, 10032, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A smarter way to track lung disease? new platform aims to personalize COPD and IPF care
- Could your own lung cells heal COPD? a new stem cell trial aims to find out
- Breathing easy: dynamic x-rays may spot COPD faster and safer
- Common mucus-thinning drugs may improve outcomes in COPD patients with lung cancer
- Could a simple screening strategy uncover hidden TB in COPD patients?
- Routine blood test may reveal hidden clues in COPD emergencies